β2-adrenergic agonists and doping: Where do we stand?
Allergy
.
2021 Jul;76(7):2320-2321.
doi: 10.1111/all.14830.
Authors
Olga Lourenço
1
2
,
Ana Cardoso
1
,
Beatriz Mónico
1
,
Jorge M R Gama
3
,
Henrique P Neiva
4
5
,
Daniel A Marinho
4
5
Affiliations
1
Faculty of Health Sciences, University of Beira Interior, Covilhã, Portugal.
2
CICS-UBI Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
3
Centre of Mathematics and Applications (CMA-UBI), University of Beira Interior, Covilhã, Portugal.
4
Department of Sport Sciences, University of Beira Interior, Covilhã, Portugal.
5
Research Center in Sports Sciences, Health Sciences and Human Development, CIDESD, Covilhã, Portugal.
PMID:
34192372
DOI:
10.1111/all.14830
No abstract available
Publication types
Letter
Comment
MeSH terms
Adrenergic beta-2 Receptor Agonists / adverse effects
Asthma*
Doping in Sports*
Humans
Sympathomimetics
Substances
Adrenergic beta-2 Receptor Agonists
Sympathomimetics